Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2020 May 6;15(5):e0232339. doi: 10.1371/journal.pone.0232339

Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the Grey-headed flying fox (Pteropus poliocephalus)

Wayne S J Boardman 1,*, Michelle L Baker 2, Victoria Boyd 2, Gary Crameri 2, Grantley R Peck 3, Terry Reardon 4, Ian G Smith 1,5, Charles G B Caraguel 1,#, Thomas A A Prowse 6,#
Editor: Wanda Markotter7
PMCID: PMC7202650  PMID: 32374743

Abstract

Habitat-mediated global change is driving shifts in species’ distributions which can alter the spatial risks associated with emerging zoonotic pathogens. Many emerging infectious pathogens are transmitted by highly mobile species, including bats, which can act as spill-over hosts for pathogenic viruses. Over three years, we investigated the seroepidemiology of paramyxoviruses and Australian bat lyssavirus in a range-expanding fruit bat, the Grey-headed flying fox (Pteropus poliocephalus), in a new camp in Adelaide, South Australia. Over six, biannual, sampling sessions, we quantified median florescent intensity (MFI) antibody levels for four viruses for a total of 297 individual bats using a multiplex Luminex binding assay. Where appropriate, florescence thresholds were determined using finite mixture modelling to classify bats’ serological status. Overall, apparent seroprevalence of antibodies directed at Hendra, Cedar and Tioman virus antigens was 43.2%, 26.6% and 95.7%, respectively. We used hurdle models to explore correlates of seropositivity and antibody levels when seropositive. Increased body condition was significantly associated with Hendra seropositivity (Odds ratio = 3.67; p = 0.002) and Hendra virus levels were significantly higher in pregnant females (p = 0.002). While most bats were seropositive for Tioman virus, antibody levels for this virus were significantly higher in adults (p < 0.001). Unexpectedly, all sera were negative for Australian bat lyssavirus. Temporal variation in antibody levels suggests that antibodies to Hendra virus and Tioman virus may wax and wane on a seasonal basis. These findings suggest a common exposure to Hendra virus and other paramyxoviruses in this flying fox camp in South Australia.

Introduction

The emergence of zoonoses from wildlife represents an increasingly significant threat to global public health [1]. Bats (Order Chiroptera) are the reservoir host of several significant groups of emerging zoonotic viruses including the paramyxoviruses, (e.g. Hendra virus and Nipah virus), coronaviruses, filoviruses and lyssaviruses [25]. In Australia, spill-over of three viruses associated with bats of the genus Pteropus, also known as flying foxes, has led to morbidity and mortality in domestic animals and humans. They include two paramyxoviruses, Hendra virus and Menangle virus, and a rhabdovirus, Australian bat lyssavirus [610]. Research into the ecology of these viruses led subsequently to the discovery of several new paramyxoviruses, including Cedar virus, Hervey virus, Yeppoon virus, Grove virus, Teviot virus [11] and Tioman virus [12]. Tioman virus, closely related to Menangle virus [8] is the only one of these viruses to be associated with disease. It has been associated with sub-clinical infection in humans and still births and fetal abnormalities in pigs [13].

The Grey-headed flying fox (Pteropus poliocephalus), one of four species of flying foxes found on mainland Australia, is classified nationally as vulnerable under the Environment Protection and Biodiversity Conservation Act 1999 [14]. The geographical distribution and migration of Grey-headed flying foxes and other pteropodids is dictated by the distribution and phenology of food plants. These bats regularly move long distances in search of ephemeral floral and fruit resources in native forests [15,16]. Aggregations of flying foxes can increase rapidly during highly productive flowering events [17]. Recently, Grey-headed flying foxes were distributed from Ingham in Queensland along the coastal belt of eastern Australia to Melbourne in Victoria. As natural food resources have declined coincident with substantial (c. 75%) loss of native forest throughout the south-eastern coastal areas of Australia, Grey-headed flying foxes have sought alternative food sources, sometimes forming new colonies in urban landscapes [18,19].

Habitat loss and fragmentation reduce not only the quantity of food available to wildlife, but also the connectivity of foraging patches, particularly if seasonally important resources have been removed [16]. In contrast, anthropogenic resource subsidies, which favour monoculture (e.g., fruit orchards) and introduced species, change the composition and seasonality of available food and the overall nutritional landscape [16]. Recently, Grey-headed flying foxes formed camps in Canberra and western parts of Victoria and, during the 2010 winter, approximately 1300 individuals migrated to Adelaide, South Australia, thereby expanding the former range of the species. Since that time, the population in Adelaide’s Botanic Park, which is a popular recreational location, has increased to approximately 20,000 individuals due to births and continued immigration(November 2019), despite seasonal emigration and substantial bat mortality events during extreme heat waves in summer. Concerns have been raised that the bat camp may constitute a biohazard to the public and to domestic animals. Indeed, Australian bat lyssavirus was detected in a Grey-headed flying fox from the camp in 2012 [20]. Since then, another twenty-six Grey-headed flying foxes from the camp were opportunistically tested for the virus of which none tested positive. However, uncertainty remains about the endemicity of Australian bat lyssavirus in the Adelaide camp.

When investigating the infection dynamics of emerging viruses in bat colonies, direct viral detection and identification is important but is technically limited due to restricted distribution of the virus in organs and transient viral shedding in biological fluids. Complementing virus detection, the exposure to specific viruses can be measured by detecting antibodies against those viruses in bat sera. Antibodies are generally present for months or even years even if the virus is scarely distributed or even after it is cleared from the animal. As a result, viral seroprevalence monitoring has often been the first line of investigation for emerging bat zoonoses [2125]. However, interpreting serological results is challenging [26] in part due to variation in the magnitude and longevity of antibody responses to different viruses, and the time of collection of serum post infection [27]. Furthermore, antibodies may cross-react with or cross-neutralize related viral antigens, which can limit the specificity of assays.

Serum viral neutralization tests (SNTs) have been considered the reference method for detecting specific antibodies to Hendra virus [28]. However, the use of SNTs is logistically constraining because the highest level of biocontainment (Biosafety level 4) is required to maintain the live viral cultures used for the neutralization assays. Instead, IgG enzyme-linked immunosorbant assays (ELISAs) and Luminex based assays [29] have been favoured because they can be performed under standard biosafety conditions [30]. Luminex based fluorescent microsphere binding assays [29] are a sensitive method for detection and quantification of antibodies against Hendra and Nipah viruses [15, 22, 31, 32] and Australian bat lyssavirus [33] in bat sera. The target antigen for Hendra virus and Cedar virus is recombinant soluble G protein [32] while the target antigens for Tioman virus and Australian bat lyssavirus are nucleoproteins. Luminex assays have been used internationally to detect henipavirus antibodies in bats and other species; including West African fruit bats and domestic pigs [22,3436], pteropodid bats in Papua New Guinea [15] and Pteropus vampyrus bats in Indonesia [37].

Serological evidence of infection with Hendra virus has been shown in all four species of pteropodid bat that occur on mainland Australia, throughout their respective ranges [21, 38]. There is evidence to suggest that two species, namely the Black flying fox (Pteropus alecto) and the Spectacled flying fox (P. conspicillatus), play the most active role in the transmission of Hendra virus to horses [38]. Hendra virus is shed in the urine, an important vehicle for transmission in Black flying foxes [10, 3839], and the virus has been detected in Grey-headed flying fox uterine fluid which provides evidence for possible transmission at birthing period which lasts from late September to early December [40] in this species [41, 42].

Here, we surveyed the exposure of Adelaide’s recently established Grey-headed flying fox population to protein antigens of Hendra virus, Cedar virus, Tioman virus and Australian bat lyssavirus over a three year period. We used results from Luminex antibody binding assays to develop a finite-mixture model to identify thresholds for defining seropositive flying foxes to characterise seroprevalence for these four viruses. Next, we used a negative-binomial hurdle model and investigated individual-level correlates of (i) seropositivity and (ii) antibody level following seroconversion. We hypothesised that Hendra virus seroprevalence and antibody levels would be associated with reproductive status as previously reported [21,23] and that Australian bat lyssavirus seroprevalence would be apparent given the prior finding of an individual carrying the virus in 2012 [20].

Materials and methods

We followed the Consortium for the Standardization of Influenza Seroepidemiology (CONSISE) guidelines [43] for the reporting of seroepidemiologic studies. Animal Ethics approval was obtained from The University of Adelaide (S-2015-028) and a wildlife scientific permit from the SA Department of Environment and Water (M-23671-1,2 and 3) prior to commencement of this project.

Sampling

Study population

The target and source population were the grey-headed flying foxes from the only known camp in SA (Fig 1) and established in Adelaide’s Botanic Park [approximate GPS coordinates: 34°54'56 S, 138°36'24 E]. The camp was sampled over six surveys at approximately six-month intervals between August 2015 (winter) and February 2018 (summer), with the aim of trapping > 50 animals per survey, which constituted our study population.

Fig 1. Location of the Grey-headed flying fox camp in Adelaide’s Botanic Park and relationship to central Adelaide and Southern Australia.

Fig 1

Location and extent (red line) of the Grey-headed flying fox camp in Adelaide’s Botanic park, showing proximity to Adelaide Zoo where bats were processed. Insets illustrate central Adelaide and Southern Australia to show geographical relationships. Geodata from OpenStreetMap was downloaded via the Maperitive application and the map was rendered with further information supplied by the author.

Bat handling, serum and data collection

Study animals were captured at the roost site using 12 or 18 m long mist nets (Ecotone, Gdynia, Poland) installed beneath the camp. Mist nets were raised 20 m above the ground before bats returned from their nightly foraging activity. As each bat became entrapped, the net was lowered, the bat handled with care using thick leather gloves to assure handlers’ health and safety, then transferred into pillow cases and relocated to the Animal Health Department of the adjacent Adelaide Zoo. The net was then elevated to 20 m above the ground to catch further bats. This continued until all bats had returned to the camp. Isoflurane (Isoflurane, Laser Animal Health) was used to anaesthetise bats during data and sample collection following the protocol described by Jonsson et al, 2004 [44]. Each bat was permanently identified using a passive integrated transponder tag (Trovan, Microchips Australia Pty, Keysborough, Victoria) inserted subcutaneously between the scapulae. A small amount of fur was clipped from the chest to rapidly identify recaptures at a given survey. In order to prevent dehydration during their short term confinement, 20–40 mL Hartmann’s fluid were injected subcutaneously between the scapulae. Approximately 3–4 mL of blood was collected via venepuncture of the propatagial or brachial vein into 4 mL serum tubes using 22-gauge needles and 3–5 mL syringes. These were allowed to clot overnight at room temperature and then at 4°C before centrifugation (5,000 rpm for 5 minutes) and separation of serum, which was subsequently stored at -80°C. After sampling, bats were placed into pillowcases to fully recover from the anesthesia before release into the camp.

For each bat, we recorded: (i) sex, (ii) body weight (BW; g), (iii) body condition score (scale of 1 to 5 based on physical palpation of the pectoral musculature by the same person), (iv) forearm length (FAL; mm); elbow to wrist length using vernier callipers, (v) estimated age as described by Hall and Richards [40] (including teeth wear, nipple size for females and enlarged penis/testes for males), (vi) reproductive status (for females; pregnant vs not pregnant by abdominal palpation, lactating vs non lactating by expression of milk and for males; enlarged penis/testes vs small penis/testes). For an objective estimate of the body condition, we also derived a body condition index (BCI) for each individual, calculated subsequently as BCI = 1,000*(BW/FAL2).

Serology for Hendra virus, Cedar virus, Tioman virus and Rabies virus

Serum samples experienced two freeze/thaw cycles prior to testing. Antibodies against Hendra virus, Cedar virus, Tioman virus, and Australian bat lyssavirus antigens were detected at the Australian Animal Health Laboratory in Geelong, Victoria using multiplex microsphere assays (Luminex, Austin, USA) as described previously [29]. The conformational status of the viruses used were the following; soluble native-like oligomeric G envelope glycoproteins of HeV and CedV (sGtet) were produced from stable expressing FreeStyleTM 293F cell lines [45,46], Tioman virus was a nucleocapsid protein expressed in the yeast Saccharomyces cerevisiae [47], and Australian bat lyssavirus was a nucleocapsid protein prepared in E.coli [48]. Briefly, prior to analysis, serum samples were first heat treated at 56°C for 30 minutes to inactivate complement then the assay proteins were coupled to individual microsphere bead sets, of predetermined numbers of magnetic beads, MagPlex® (Luminex, Northbrook, USA). These were added to each well and then mixed with bat sera at a dilution of 1:50. The bound antibody was detected using biotinylated Protein A (Pierce, Rockford, USA) together with biotinylated Protein G (Pierce, Rockford, USA) followed by streptavidin–phycoerythrin (Qiagen Pty Ltd, Australia). The assay was read using a Bio-Plex Protein 200 Array System integrated with Bio-Plex Manager Software (v 6.2) (Bio Rad Laboratories, CA, USA) calibrated on the high setting. Each sample was tested in a well with thousands of beads and the florescence results of 100 beads were recorded as the median florescent intensity (MFI) that excludes outliers and are correlated with antibody concentration. Positivity thresholds for the Luminex serological assay have not been defined for Australian flying foxes due to the lack of negative and single-infection control serum [32] and were therefore estimated using finite mixture modelling (see below).

Statistical analysis

Demographic analysis

Two-sample t-test statistics were used to identify any differences in BW, FAL and BCI across demographic classes (sub-adult males and females and adult males and adult pregnant and non pregnant females) and between winter and summer.

Estimating MFI thresholds for classifying seropositive animals

MFI values were log-transformed prior to analysis to approximate a normal distribution and enable parametric analyses. We used finite mixture modelling in the statistical package Stata v15.1 (College Station, Texas, USA) to identify the presence of more than one sub-population under the assumption of normal distribution. Models assuming up to three mixed distributions were run and their parsimony compared using Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC). The model with the lowest AIC and/or BIC was selected as final. When the single distribution model fitted best, the distribution was assumed to be the non-seroconverted bats if MFI values were in the lower end of the range and seroconverted bats if in the higher end of the range. When the two distributions model fitted best, the distributions were considered as the non-seroconverted and the seroconverted bats, respectively, according to their values’ range. When the three distributions model fitted best, the distribution with the lowest value range was considered as the non-seroconverted bats and the other two distributions (with higher value ranges) as two sub-groups of seroconverted bats. When two distributions fully overlapped, these were considered as one single distribution because the readings had no discriminative ability. For best fit models with more than one mixed distribution that overlapped partially, threshold values were determined visually at the MFI value for which two predicted normal distributions intersected. These threshold values were used to classify (imperfectly) individual bats as ‘seronegative’ or ‘seropositive’ (or ‘intermediate positive’ when three distributions were identified).

Hurdle modelling of seropositivity and antibody levels

To investigate correlates of seropositivity and MFI levels, we used a hurdle regression model which included two components; (i) the ‘hurdle’ component, which modelled the probability of being seropositive (as defined using the estimated lower threshold value); and (ii) a negative binomial count component, which modelled the antibody value (expressed as MFI) conditional on seropositivity. Explanatory variables investigated were those measured or observed during the trapping i.e. sex (male or female), age class (subadult < 2.5 years or adult ≥ 2.5 years), body weight (g), forearm length (mm), catching session (1–6), season (winter or summer), pregnancy status, lactation status, and body condition index (BCI). However, we excluded the effect of season from the final model due to strong collinearity between season and time of survey. Hurdle models were implemented within the R software for statistical computing (version 3.2.3) using the package pscl. The extent of co-seropositivity for all four viruses was also assessed using the negative binomial hurdle regression model investigating the same explanatory variables.

Demonstration of zero seroprevalence for Australian bat lyssavirus

The probability that the Adelaide camp is free from Australian bat lyssavirus was estimated using the historical survey analysis outlined by Cameron (2014) [49]. The probability of freedom from Australian bat lyssavirus was uncertain before the first survey and a prior value of 50% was used. In the absence of published information on the diagnostic accuracy of the multiplex Luminex assay, we optimistically assumed that this method had perfect accuracy for Australian bat lyssavirus antibodies. Similarly, little information is available on differential risks of Australian bat lyssavirus exposure across bat demographics. Therefore, the risk of Australian bat lyssavirus exposure’ was assumed constant across the bat camp strata (i.e. risk independent modelling). The ‘open’ nature of our study population was taken into account by including a ‘between-survey’ probability of exposure from and/or introduction of immigrating exposed bats into the model. Freedom from Australian bat lyssavirus seroprevalence was deemed achieved if the estimated probability of freedom was ≥ 95%.

Results

Demographic information

A total of 301 Grey-headed flying foxes were captured over six surveys. Four individual flying foxes were recaptured once each during this period. Demographics including sex, age, weight, forearm length and BCI varied across seasons reflecting the seasonality of the species’ reproduction and feeding opportunities (Tables 1 and 2). Approximately, two thirds were females and two thirds were adults. The overall percentage of adults was similar between sexes (61.7% vs 69.9%). Among the adult females, 31.9% (37/116) were pregnant at capture. Sex and age-class representation was similar across sampling and seasons. Overall the BCI was higher in winter (mean = 28.2, range = 20.2–36.1) than summer (mean = 25.3, range = 13.8–35.8) (+ 2.9 units, p < 0.001) mainly driven by the sub-adult BCI being higher in winter (n = 52, mean = 25.8, range = 20.2–29.6) than summer (n = 52, mean = 21.1, range = 13.8–29.2) (+4.7 units, p < 0.001).

Table 1. Summary demographic statistics–all captures.

BW (g) FAL (mm) BCI
Demographic Classes n Mean (SD) Range n Mean (SD) Range n Mean (SD) Range
Sub-adult (all) 106 550 (115.4) 266–772 104 153.0 (7.3) 127.0–171.0 104 23.5 (3.6) 13.8–29.6
Sub-adult Females 72 566 (110.8) 291–739 70 153.8 (6.8) 140.0–170.5 70 23.9 (3.6) 13.8–29.6
Sub-adult Males 34 517 (119.5) 266–772 34 151.7 (7.8) 127.3–162.6 34 22.6 (3.4) 16.4–29.2
Adult (all) 195 764 (90.0) 563–1,008 193 164.0 (4.8) 152.0–176.8 104 23.5 (3.6) 13.8–29.6
Adult Females 116 743 (78.7) 563–1,005 114 163.0 (4.7) 152.0–174.4 114 27.9 (2.8) 22.0–35.1
    Pregnant 37 792 (91.6) 600–1005 37 162.3(5.0) 152.0–171.4 37 30.0 (2.7) 22.8–34.9
    Not Pregnant 79 720 (60.0) 563–963 79 164.0 (4.6) 154.0–173.0 79 27.0 (2.3) 22.0–35.2
Adult Males 79 794 (96.0) 585–1,008 79 165.2 (4.7) 155.1–176.8 34 29.1 (2.8) 22.6–36.1
All Females 188 676 (126.1) 291–1,005 184 159.5 (7.2) 140.0–173.4 184 26.4(3.7) 13.8–35.2
All Males 113 711 (164.2) 266–1,008 113 160.6 (9.0) 127.3–176.8 113 27.1 (4.2) 16.4–36.1
Total 301 689 (142.4) 266–1,008 297 160.0 (8.0) 127.3–176.8 297 26.7 (3.9) 13.8–36.1

Summary demography statistics (number (n), mean, standard deviation (SD), range) of 301 Grey-headed flying foxes captured over six surveys between September 2015 and February 2018 from the Adelaide Camp, Botanic Park, Adelaide. BW = Body weight, FAL = forearm length, BCI = body condition index = 1,000*(BW/FAL2)

Table 2. Summary demographic statistics–winter versus summer.

  WINTER SUMMER
  BW (g) FAL (mm) BCI BW (g) FAL (mm) BCI
Demographic Classes n Mean (SD) Range n Mean (SD) Range n Mean (SD) Range n Mean (SD) Range n Mean (SD) Range n Mean (SD) Range
Sub-adult 53 628.6 (42.8) 516–695 52 156.3 (4.1) 146.0–166.0 52 25.8 (2.0) 20.2–29.6 53 472(112.0) 266–772 52 149 (7.8) 127.0–161.0 52 21.1(3.3) 13.8–29.2
Females 40 629 (44.5) 516–695 39 156.2 (4.2) 147.0–166.0 39 25.9 (2.1) 20.2–29.6 32 486 (118.0) 291–739 31 150.5 (8.0) 140.0–170.5 31 21.3 (3.5) 13.8–29.0
Males 13 626 (38.6) 559–675 13 156.4 (3.8) 147.8–162.0 13 25.6 (1.6) 22.7–28.4 21 449 (100.7) 266–772 21 146.1 (7.0) 127.3–162.6 21 20.8 (2.8) 16.4–29.2
Adult 90 790 (99.2) 585–1008 90 163.3 (5.0) 152.0–173.0 90 29.5 (2.9) 22.6–36.1 105 741 (77.3) 563–992 103 164.5 (4.6) 153.5–176.8 103 27.4 (2.4) 22.0–35.8
    Females 46 780 (92.5) 600–1005 46 162.1 (4.9) 152.0–171.4 46 29.6 (2.8) 22.8–34.9  70 719 (56.7) 563–963 68 163.8 (4.5) 153.5–173.4 68 26.8 (2.2) 22.0–35.2 
    Pregnant 37 792 (91.6) 600–1005 37 162.3 (5.0) 152.0–171.4 37 30 (2.7) 22.8–34.9 N/A N/A N/A. N/A. N/A. N/A. N/A. N/A. N/A.
    Not Pregnant 9 732 (84.9) 645–844 9 161.1 (4.4) 155.1–168.4 9 28.2 (2.8) 24.1–32.6 70 719 (56.7) 563–963 68 164 (4.5) 154.0–173.0 68 26.8 (2.2) 22.0–35.2
Males 44 800 (105.8) 585–1,008 44 164.6 (4.8) 155.1–173.1 44 29.4 (3.0) 22.6–36.1 35 787 (82.9) 622–992 35 165.8 (4.6) 158.1–176.8 35 28.6 (3.1) 24.0–35.8
Total Females 86 710(105.5) 516–1,005 85 159.4 (5.4) 147.0–171.4 85 27.9 (3.1) 20.2–34.9 102 646 (134.7) 291–963 99 160 (8.5) 140.0–173.0 99 25.1 (3.7) 13.7–35.1
Total Males 57 761 (119.9) 559–1,008 57 162.8 (5.7) 147.8–173.1 57 28.6 (3.2) 22.6–36.1 56 660 (187.4) 266–992 56 158.5 (11.1) 127.3–176.8 56 25.7 (4.6) 16.4–35.8
TOTAL 143 730 (113.8) 516–1,008 142 160.7 (5.8) 147.0–173.1 142 28.2 (3.1) 20.2–36.1 158 651 (155.0) 266–992 155 159.2 (9.5) 127.3–176.8 155 25.3 (4.0) 13.8–35.8

Seasonal demography statistics (number (n), mean, standard deviation (SD), range, winter and summer) of 301 Grey-headed flying foxes captured over six surveys between September 2015 and February 2018 from the Adelaide Camp, Botanic Park, Adelaide. BW = Body weight, FAL = forearm length, BCI = body condition index = 1,000*(BW/FAL)2

Serology thresholds and serological prevalence

Multiplex serology was conducted on 301 serum samples (comprising 297 individual bats, with 4 recaptures). With the exception of Australian bat lyssavirus, these assays yielded multi-modal distibutions for log-transformed MFI (Fig 2). Three mixed distributions were identified for Hendra virus, Cedar virus and Tioman virus, and two cut-offs, a lower and upper, were determined visually (Fig 2). Upper and lower thresholds for the Hendra virus serology were determined as the natural antilogorithms of 5.85 and 8.67, respectively (MFI 347 and 5825, respectively). Upper and lower thresholds for the Cedar virus serology were determined as the natural antilogorithms of 5.76 and 7.44, respectively (MFI 317 and 1702, respectively). Upper and lower thresholds for the Tioman virus serology were determined as the natural antilogorithms of 6.37 and 7.38 respectively (MFI 584 and 1603, respectively). A single distribution of assumed non-seroconverted animals was identified for Australian bat lyssavirus. Using the lower threshold values, 26.6% of the bats were seropositive for Cedar virus, 43.2% of the bats for Hendra virus and 95.7% of the bats for Tioman virus were seropositive (Table 3).

Fig 2. Density histogram and overlaid mixture of modelled distributions.

Fig 2

Density histogram and overlaid mixture of modelled distributions for MFI and the natural log MFI of A) Hendra virus, B) Cedar virus, C) Tioman virus and D) Australian bat lyssavirus serological readings. Thresholds (dashed vertical lines) correspond to the intersection between a pair of predicted distributions. Upper and lower thresholds for the Hendra virus serology were determined as the natural antilogorithm of 5.85 and 8.67, respectively (MFI 347 and 5,825, respectively). Upper and lower thresholds for the Cedar virus serology was determined as the natural antilogorithm of 5.76 and 7.44 respectively (MFI 317 and 1,702 respectively). Upper and lower thresholds for the Tioman virus serology was determined as the natural antilogorithm of 6.37 and 7.38 respectively (MFI 584 and 1,603 respectively). Upper and lower thresholds could not be calculated for Australian bat lyssavirus as it was determined that all animals belong to the same exposure sub-population.

Table 3. Lower threshold MFI scores with corresponding % seroprevalence.

Virus Lower MFI threshold (log MFI) % seroprevalence (Binomial exact 95% CI) MFI median values (range) for seropositive animals
Hendra virus 347 (5.85) 43.2% (37.5%-49%) 6,813 (353–23,922)
Cedar virus 317 (5.76) 26.6% (21.7%-31.9%) 3,074 (326–13,759)
Tioman virus 584 (6.37) 95.7% (92.7%-97.7%) 2,121 (629–4,972)
Australian bat lyssavirus Na 0% (0.0%- 1.22%) Na

Lower thresholds including median fluorescence intensity (MFI) and log MFI and seroprevalence with confidence intervals (CI) for Hendra virus, Cedar virus, Tioman virus and Australian bat lyssavirus for Grey-headed flying foxes sampled in Adelaide, South Australia between September 2015 and February 2018 (n = 301). na = not applicable.

Hurdle modelling of seropositivity and antibody levels

Using lower threshold levels, the probability of Hendra virus seropositivity was positively and significantly associated with body condition index (Odds ratio = 3.67, p = 0.002). Cedar virus seropositivity was not associated with any of the investigated factors. 95.7% of all bats were Tioman virus seropositive and the hurdle model could not converge because of saturation (Table 4 and Fig 3). Using the antibody level model, Hendra virus antibody MFI levels were significantly higher in pregnant seropositive females and at the second survey in February 2016 (when 57.4% of individuals were seropositive). However, Hendra virus antibody MFI levels were significantly lower at the fifth survey in September 2017 when 37.0% of individuals were seropositive. Tioman virus MFI antibody levels were significantly higher in adults than sub-adults and at the fifth catching session in September 2017 (Table 4 and Fig 3). There was no evidence of co-seropositivity among the four viruses.

Table 4. Statistics for hurdle and antibody level models.

 MODEL   Hendra virus   Cedar virus   Tioman virus
 HURDLE Estimate OR (95% CI) SE Z value P value Estimate OR (95% CI) SE Z value P value Estimate OR (95% CI) SE Z value P value
Intercept -0.311 - 0.204 -1.526 0.127 -0.996 - 0.221 -4.5 <0.001 . . . . .
Adult male -0.036 -1.04 0.308 -0.118 0.906 -0.298 -1.34 0.352 -0.847 0.397 . . . . .
Female Not Preg 0.04 1.04 0.313 0.127 0.899 0.407 1.5 0.33 1.235 0.217 . . . . .
Female Preg 0.057 1.05 0.379 0.151 0.88 -0.587 -1.8 0.471 -1.246 0.213 . . . . .
BCI centred 1.3 3.67 0.416 3.126 0.002 -0.27 1.31 0.451 -0.598 0.55 . . . . .
ANTIBODY LEVEL Estimate SE Z value P value Estimate SE Z value P value Estimate SE Z value P value
Intercept 8.717 0.218 40.027 <0.001 7.616 0.347 21.96 <0.001 7.543 0.07 108.318 <0.001
Adult male 0.067 0.228 0.295 0.768 0.365 0.308 1.185 0.236 0.227 0.062 3.667 <0.001
Female Not Preg -0.15 0.205 -0.732 0.464 0.133 0.316 0.42 0.675 0.161 0.068 2.374 0.018
Female Preg 0.865 0.281 3.073 0.002 0.797 0.446 1.787 0.074 0.394 0.084 4.685 0
BCI centred 0.346 0.315 1.099 0.272 -0.113 0.461 -0.245 0.806 0.097 0.091 1.064 0.287
16-Feb 0.715 0.258 2.766 0.006 0.436 0.469 0.93 0.353 -0.107 0.087 -1.231 0.218
16-Aug -0.218 0.295 -0.739 0.46 -0.045 0.489 -0.092 0.927 -0.066 0.086 -0.761 0.447
17-Feb -0.209 0.291 -0.719 0.472 0.78 0.43 1.813 0.07 -0.122 0.091 -1.341 0.18
17-Aug -0.583 0.271 -2.152 0.031 0.093 0.477 0.194 0.846 -0.192 0.088 -2.191 0.028
18-Feb 0.374 0.336 1.113 0.266 0.645 0.531 1.213 0.225 0.087 0.096 0.907 0.365

Odds ratios (OR), estimates, standard errors (SE), Z values and P values for negative binomial hurdle and antibody level models for Hendra virus, Cedar virus and Tioman virus serology for Grey-headed flying foxes sampled between August 2015 and February 2018. Reference values relate to sub-adults (both male and female) for the hurdle and antibody level model and for the first catching session (August 2015) for the antibody level model. Preg = pregnant. BCI centred = body condition index centred around the mean values. CI = confidence interval.

Fig 3. Effect plots for hurdle and antibody level models.

Fig 3

Effect plots for the estimates and P values for negative binomial hurdle and antibody level models for Hendra virus, Cedar virus and Tioman virus serology for Grey-headed flying foxes sampled between August 2015 and February 2018.

Investigation of freedom from Australian bat lyssavirus seroprevalence

None of the tested bats yielded a MFI high enough to imply seroconversion. Accounting for the number of bats captured at each sampling session, there was enough evidence to demonstrate, with 95% confidence, that the Australian bat lyssavirus sero-prevalence is less that 2%, assuming that the probability of the camp to be exposed (or an immigrating bat being exposed) between samplings was ≤ 5% (Table 5). There was not enough evidence to demonstrate with confidence a seroprevalence ≤ 1% regardless of the probability of exposure.

Table 5. Probablity of freedom from Australian bat lyssavirus exposure.

Probability of exposure
Design prevalence (P*) 0.5% 1% 2% 5% 10.0%
1% 94.6% 93.8% 92.2% 87.2% 78.4%
2% 99.5% 99.2% 98.6% 96.7% 93.3%
5% 100.0% 99.9% 99.8% 99.6% 99.1%
10% 100.0% 100.0% 100.0% 100.0% 99.9%

Summary of final probability of freedom from Australian bat lyssavirus exposure after 6 surveys of a total 301 bats (all seronegative) from the Adelaide Grey-headed flying fox camp. Bold types represent values of probability of freedom where a minimum threshold of 95% was reached.

Recapture seroprevalence analysis

Over the six sessions, four bats were recaught; three males and one female (Table 6). Between survey one and two, September 2015 and February 2016, respectively, the Hendra virus MFI antibody level for one male almost doubled from MFI 9428 to 16929, suggesting exposure occurred prior to September 2015 and continued until February 2016 or reinfection or recrudescence of Hendra virus occurred during this same period. This male’s weight also increased as it was classified as a sub-adult in September 2015 and an adult in February 2016. Another male seroconverted for Cedar virus between Sept 2015 and Feb 2016, suggesting exposure occurred during that period. All four animals were seropositive for Tioman virus at both sampling periods while two males did not seroconvert for Hendra virus and thus remained seronegative between the two six month time periods. Furthermore, two males and one female did not show evidence of exposure to Cedar virus between sampling periods.

Table 6. Seroprevalence changes in recaptured Grey-headed flying foxes.

Bat ID Date of capture Sex Wt /g BCI Hendra virus MFI Hendra virus seropositive Cedar virus MFI Cedar virus seropositive Tioman virus MFI Tioman virus seropositive Australian bat lyssavirus MFI Australian bat lyssavirus seropositive
6 & 72 31 Aug 2015 F 844 29.8 772 - 139 - 2797 + 136 -
26 Feb 2016 763 26.9 745 - 153 - 2355 + 91 -
23 & 70 2 Sept 2015 M 820 30.1 172 - 181 - 2592 + 130 -
26 Feb 2016 744 26.6 128 - 3073 + 1248 + 115 -
46 & 81 3 Sept 2015 M 666 25.4 9428 + 175 - 2820 + 92 -
26 Feb 2016 773 28.0 16929 + 191 - 2979 + 141 -
145 & 252 10 Aug 2016 M 818 30.7 8710 + 257 - 2217 + 204 -
13 Aug 2017 830 30.8 6335 + 210 - 3111 + 207 -

The sex, weight (Wt), body condition index (BCI) and study identification number (Bat ID) of four Grey-headed flying foxes recaptured between August 2015 and August 2017 at the Adelaide Camp, Adelaide, South Australia and their median fluorescence intensity (MFI) serostatus for Hendra virus, Cedar virus, Tioman virus (using lower thresholds) and Australian bat lyssavirus. M = Male; F = Female; Seropositive = +; Seronegative = —.

Discussion

Our study showed strong evidence of exposure of Adelaide Grey-headed flying fox camp to Hendra virus, Cedar virus and Tioman virus and no evidence of exposure to Australian bat lyssavirus. The semiquantitative results provided by Luminex binding assays also identified individual-level correlates of seroposivity and antibody levels. Hendra virus seroprevalence in this study (43.2%, 95%CI: 37.5%-49%) is similar to that reported previously (44.5%) [31] using a Luminex binding assay and compares with an overall seroprevalence of 23.6% using a serum neutralisation test in Little red flying foxes (P.scapulatus) [23] and an overall seroprevalence of 56% using a serum neutralisation test in Spectacled flying foxes [21]. Cedar virus seroprevalence was half than previously reported; 26.6% (95%: 21.7%-31.9%) versus 51.1% in Grey-headed flying foxes [31]. There were some differences in the exposure rates within the camp and across the study sampling times.

Hendra seropositivity was also positively associated with BCI. This contrasts with a previous study [23] which found increased seropositivity in nutritionally-stressed Little-red flying foxes but concurs with a study [10] in Black flying foxes and Grey-headed flying foxes. In our study, the body condition index of bats was significantly higher in winter than summer (Table 2). Food quantity and quality for Grey-headed flying foxes are usually inferior in winter elsewhere in their normal range [50]. Winter immigration of approximately 5–10,000 extra Grey-headed flying foxes into the Adelaide camp (Van Weenan pers comm) in 2018 and 2019 suggests that Adelaide is an attractive feeding ground during winter. Other studies indicate acute food shortages may be associated with El Nino/La Nina climate cycles [51] leading to nutritionally stressed animals and this may be the driver for the seasonal patterns of Hendra virus seroprevalence [23, 52]. Late gestation was positively associated with higher Hendra virus MFI antibody levels in comparison to non-pregnant females and males. SImilar evidence is seen in serological surveys of Spectacled flying foxes [21] and Little-red flying foxes [23] which showed increased detection of Hendra virus antibodies associated with late-stage gestation or early lactation but is in contrast to recent research in Grey-headed flying foxes [10] where there is no association.

Hendra virus and Tioman virus seropositivity varied across surveys (Fig 3) with Hendra virus seroprevalence significantly increasing between August 2015 and February 2016. This pattern could be explained by: i) “exposure and spread in a sedentary camp” where a Hendra virus exposure event that occurred before August 2015 (seroprevalence = 49%) and resulted in an increase in seroprevalence of captured animals in February 2016 (seroprevalence = 57%) without any further exposure occurring in this period (i.e. within camp spread) and negligible emigration/immigration; or ii) “exposure and re-exposure in a sedentary camp” where additional Hendra virus exposure occurred between the two sampling periods which led to an higher seroprevalence at the second sampling period and negligible emigration/immigration; or iii) “periodic emigration” of non-exposed animals and/or “periodic immigration” of previously exposed flying foxes occurred during this period. Previous studies have suggested that Hendra virus is maintained in flying fox populations through episodic infection in a metapopulation structure, and do not persist endemically within a single population [23]. Most hypotheses emphasize horizontal transmission within colonies via urine and other secretions, especially during pregnancy and mating [23], or via migration, with the magnitude of migration affected by the spatial connectivity among colonies, resulting in episodic infection [53].

The recaptures of four individuals over the sampling period provided some information on the immunity dynamics of these viruses within this specis. Two of these animals were not exposed to Hendra virus and thus remained seronegative between the two captures (six month time period for both). However, one animal’s Hendra virus seropositive MFI antibody level nearly doubled over a six month time period; between September 2015 and February 2016 which could mean: i) it was recently exposed just before the first sampling and the antibody level continued to rise in response to the second sampling; ii) it was exposed some time before the first sampling and the antibody level peaked between the two captures and was waning at the second; or iii) it was exposed some time before the first sampling and was re-exposed between captures and mounted a further antibody response. Epstein et al, 2013 [30] suggests maternal antibodies to Hendra virus in Black flying foxes last between 7.5 and 8.5 months and acquired immunity to African henipaviruses may last up to 4 years in adult Eidolon helvum adults [54] but evidence on Grey-headed flying foxes immune response to viruses is sparse. The antibody level of another seropositive animal waned over one year between August 2016 and 2017, suggesting that the animal was less likely to have become further infected (August 2016 to August 2017). The fourth animal was seropositive and its antibody level waned over one year (August 2016 to August 2017), suggesting that this animal was unlikely re-exposed during this period.

None of the explored explanatory variable predicted Cedar virus serostatus which is consistent with previous reports [31]. Furthermore there was no evidence of association between the serostatuses of any pair of viruses. Adult bats showed significantly higher antibody levels against Tioman virus in comparision to subadults which may suggest there is a cumulative age-related antibody response to multiple exposures of the virus. Additionally, immunofluorescent antibody and immunoelectron microscopic data suggested that Tioman virus is antigenically related to Menangle virus [12] so it is possible that the high seropositivity to Tioman virus could result from the cross reactivity with Menangle virus exposure.

No evidence of Australian bat lyssavirus exposure was found over our study period despite a previous finding of a positive diagnosis in a Grey-headed flying fox in the Adelaide camp in September, 2012 [20]. Previous serological surveys have found a 3.0% Australian bat lyssavirus seroprevalence in flying foxes (95% CI: 1.5–5.8%)[55] using the rapid fluorescent focus inhibition test and 2.9% seroprevalence (95% CI: 1.8–4.5%) in six insectivorous species in Western Australia using a Luminex multiplex binding assay [33]. Rabies virus neutralising antibodies have been shown to wane in experimentally-infected bats within 6 months after an initial inoculation, but persisted for longer (6–12 months) after a second inoculation of surviving bats [56]. Our results suggest that either (i) Australian bat lyssavirus has not been circulating in the camp over this time period; (ii) seropositivity is very short lived; or (iii) infected flying foxes died suddenly and were thus not sampled at surveys. However, bats are thought to be the ancestral reservoir of lyssaviruses [57] and are the only taxa in which antibodies are detected with sufficient frequency to support serosurveillance [33] which could indicate that the virus is unlikely to be circulating in the Adelaide camp.

As with all flying fox camps, the population dynamics can often be very fluid with regular patterns of immigration, emigration and range expansions. Some studies show flying foxes can travel hundreds of kilometres [15, 55, 58], moving regularly between different camps over their distribution range. Furthermore, there is evidence that all four species of mainland Australian pteropids can co-occur in the same camp [59]. Range expansions and contractions have been noted in both Black flying foxes and Grey-headed flying foxes [18, 6061]. The range of Black flying foxes has increased southwards greater than 1000km during the twentieth century [62] and this has been proposed as a possible contributing factor to a contraction of Grey-headed flying foxes distribution range. In its southernmost distribution, Grey-headed flying foxes now live in the urban environments of Melbourne [61] and Adelaide. While these areas are not thought to be part of the ‘climatic niche’ of the species during winter, increased temperature due to the ‘urban heat island effect’ and climate change may have created an environment that is now tolerable [63]. Therefore its conceivable that through this overlap of flying fox species, transmission and infection may occur anywhere along the distribution range continuum at any time.

Microsphere assays provide a sensitive method to detect henipavirus antibody binding in fruit bat plasma and serum [15, 32, 36].The output of these assays, median fluorescence intensity (MFI), are continuous data and present a challenge in determining meaningful threshold values that categorise bats as seropositive or seronegative [36]. A MFI > 1,000 for Australian bat lyssavirus has been considered positive and < 250 negative [33]. Our use of mixture models to determine threshold values reflects that of Burroughs et al 2016 [31] in that we accept that a single threshold is not possible for the serological profile obtained for the Adelaide bats. We looked for ‘natural’ groupings of binding activity and used two threshold values to divide these groups into negative, intermediate and positive categories. We recognise that binding in the intermediate category may represent an important intermediate stage in antiviral protection, the shift from a seronegative to a seropositive state or vice versa, or may represent a susceptible state. Even using the more specific threshold (MFI 5825, 1702, 1603 for Hendra virus, Cedar virus and Tioman virus, respectively), 25.2% of bats caught from the Adelaide camp showed evidence of prior infection with Hendra virus, 16.6% with Cedar virus and 63.8% with Tioman virus which all suggest common exposures at both the individual and camp level.

We acknowledge certain limitations to our study. The most effective technique to capture bats in the Adelaide camp requires nets to be placed from suitable trees under the camp as they return from foraging. The entire foot print of bat roost trees could not be sampled using a formal random sampling approach because of the topography and may therefore consistute a potential sampling bias. Utilising the same capture sites across the whole study period attempted to standardise any potential sampling bias and protect the comparibility of samples.

Conclusion

In contrast to other studies, good body condition rather than nutritional stress was an indicator of increased Hendra virus seroconversion. Substantiating other studies, Hendra virus antibody levels were higher in pregnant females. Unexpectedly, there was no evidence of Australian bat lyssavirus seroconversion. This study highlighted the successful use of a multiplexed Luminex binding assay for serological surveys in flying foxes but also the need to expand the research to include more sampling periods over an annual cycle and to compare with viral presence and diversity.

Supporting information

S1 Table. Catching information, demographic data, morphometrics and MFI values for Hendra virus, Cedar virus, Tioman virus and Australian bat lyssa virus for each sampled bat.

(XLSX)

Acknowledgments

We thank all the volunteers who supported the capture and processing of flying foxes, especially staff from the SA Department of Environment and Water, academic colleagues, students and volunteers. A special thanks goes to Clive Boardman, Dr Michelle Power, Dr Cecilia Sanchez, and Dr Kathy Burbidge for long term support and expertise and the staff of Zoos SA for their ongoing support including Drs David and Jenny McLelland, Dr Jerome Kalvas and Dianne Hakof and Rebecca Probert. We acknowledge Dr Christopher Broder and Dr Lianying Yan, Uniformed Services University, USA for the production of the Hendra virus and Cedar virus soluble glycoproteins and Dr Kestas Sasnauskas, Institute of Biotechnology, Lithuania for the production of the Tioman virus nucleocapsid protein used in this study. Wildlife health data were provided by the Wildlife Health Australia Coordinator in South Australia and generated by the Department of Primary Industries and Regions, South Australia.

Data Availability

All relevant data are within the manuscript and its Supporting Information files.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, Gittleman JL et al. Global trends in emerging infectious diseases. Nature. 2008; 451: 990–993. 10.1038/nature06536 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Calisher CH, Childs JE, Field HE, Holmes KV, Schountz T. Clin Microbiol Rev. 2006; 19: 531–545. 10.1128/CMR.00017-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Halpin K, Hyatt AD, Fogarty R, Middleton D, Bingham J, Epstein JH et al. Pteropid bats are confirmed as the reservoir hosts of henipaviruses: a comprehensive experimental study of virus transmission. Am J Trop Med Hyg. 2011; 85: 946–951. 10.4269/ajtmh.2011.10-0567 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Smith I and Wang L-F. Bats and their virome. An importance source of emerging viruses capable of infecting humans. Curr Opin Virol. 2013; 3: 84–91. 10.1016/j.coviro.2012.11.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wong ACP, Li X, Lau SKP, Woo PCY. Global Epidemiology of Bat Coronaviruses. Viruses. 2019; 11: 174 10.3390/v11020174 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fraser GC, Hooper PT, Lunt RA, Gould AR, Gleeson LJ, Hyatt AD et al. Encephalitis caused by a lyssavirus in fruit bats in Australia. Emerg Infect Dis. 1996; 2: 327–31. 10.3201/eid0204.960408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Philbey AW, Kirkland PD, Ross AD, Field HE, Srivastava M, Davis RJ et al. Infection with Menangle virus in flying foxes (Pteropus spp.) in Australia. Aust Vet J. 2008; 86: 449–454. 10.1111/j.1751-0813.2008.00361.x [DOI] [PubMed] [Google Scholar]
  • 8.Field H, de Jong C, Melville D, Smith C, Smith I, Broos A et al. Hendra Virus Infection Dynamics in Australian Fruit Bats. PLoS One. 2011; 6 (12): e28678 10.1371/journal.pone.0028678 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Barr JA, Smith C, Marsh GA, Field H, Wang L-F. Evidence of bat origin for Menangle virus, a zoonotic paramyxovirus first isolated from diseased pigs. J Gen Virol. 2012; 93: 2590–4. 10.1099/vir.0.045385-0 [DOI] [PubMed] [Google Scholar]
  • 10.Edson D, Peel AJ, Huth L, Mayer DG, Vidgen ME, McMichael L et al. Time of year, age class and body condition predict Hendra virus infection in Australian black flying foxes (Pteropus alecto). Epid and Infection. 2019; 10.1017/S0950268819001237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Barr J, Smith C, Smith I, de Jong C, Todd S, Melville D et al. Isolation of multiple novel paramyxoviruses from pteropid bat urine. J Gen Virol. 2015; 96: 24–29. 10.1099/vir.0.068106-0 [DOI] [PubMed] [Google Scholar]
  • 12.Chua KB, Wang LF, Lam SK, Crameri G, Yu M, Wise T. Tioman virus, a novel paramyxovirus isolated from fruit bats in Malaysia. Virology. 2001; 283: 215–229. 10.1006/viro.2000.0882 [DOI] [PubMed] [Google Scholar]
  • 13.Yaiw KC, Bingham J, Crameri G, Mungall B, Hyatt A, Yu M et al. Tioman Virus, a Paramyxovirus of Bat Origin, Causes Mild Disease in Pigs and Has a Predilection for Lymphoid Tissues. J Virol. 2007; 82: 565–568; 10.1128/JVI.01660-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Threatened Species Scientific Committee (2001). Commonwealth Listing Advice on Pteropus poliocephalus (Grey-headed Flying-fox). Available from: http://www.environment.gov.au/biodiversity/threatened/species/p-poliocephalus.html. In effect under the EPBC Act from 06-Dec-2001. Accessed 6 November 2019.
  • 15.Breed AC, Yu M, Barr JA, Crameri G, Thalmann CM, Wang LF. Prevalence of henipavirus and rubulavirus antibodies in pteropid bats, Papua New Guinea. Emerg Infect Dis. 2010; 16: 1997–1999. 10.3201/eid1612.100879 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kessler MK, Becker DJ, Peel AJ, Justice NV, Lunn T, Crowley DE et al. Changing resource landscapeds and spillover of henipaviruses. Ann NY Acad Sci. 2018; 1429 78–99 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Eby P, Richards G, Collins L, Parry-Jones K. The distribution abundance and vulnerability to population reduction of a nomadic nectarivore, the grey-headed flying-fox Pteropus poliocephalus in New South Wales, during a period of resource concentration. Aust. Zool. 1999; 31: 240–253. 10.7882/AZ.1999.024 [DOI] [Google Scholar]
  • 18.Williams NSG, McDonnell MJ, Phelan GK, Keim L D and Van der Ree R. Range expansion due to urbanization: increased food resources attract grey-headed flyingfoxes (Pteropus poliocephalus) to Melbourne. Austral Ecol. 2006; 31: 190–198. 10.1111/j.1442-9993.2006.01590.x [DOI] [Google Scholar]
  • 19.Tait J, Perotto-Baldivieso HL, McKeown A, Westcott DA. Are Flying-Foxes Coming to Town? Urbanisation of the Spectacled Flying-Fox (Pteropus conspicillatus) in Australia. PLoS One. 2014; 9 (10): e109810 10.1371/journal.pone.0109810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Cox-Witten K. Australian bat lyssavirus Bat Stats. Wildlife Health Australia website. Sourced November 2019. Available from https://www.wildlifehealthaustralia.com.au/Portals/0/Documents/ProgramProjects/ABLV_Bat_Stats_Jun_2019.pdf
  • 21.Breed AC, Breed MF, Meers J, Field HE. Evidence of Endemic Hendra Virus Infection in Flying-Foxes (Pteropus conspicillatus)—Implications for Disease Risk Management. PLoS One. 2011; 6 (12): e28816 10.1371/journal.pone.0028816 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Hayman DTS, Suu-Ire R, Breed AC, McEachern JA, Wang L, Wood JLN, et al. Evidence of henipavirus infection in west African fruit bats. PLoS One. 2008; 3 (7): e 2739 10.1371/journal.pone.0002739 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Plowright RK, Field HE, Smith C, Divljan A, Palmer C, Tabor G et al. Reproduction and nutritional stress are risk factors for Hendra virus infection in little red flying foxes (Pteropus scapulatus). Proc R Soc Lond Biol. 2008; 275: 861–869. 10.1098/rspb.2007.1260 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Pourrut X, Delicat A, Rollin PE, Ksiazek TG, Gonzalez JP, Leroy EM. Spatial and temporal patterns of Zaire ebolavirus antibody prevalence in the possible reservoir bat species. J Infect Dis. 2007; 196 S176–S183. 10.1086/520541 [DOI] [PubMed] [Google Scholar]
  • 25.Plowright RK, Peel AJ, Streicker DG, Gilbert AT, McCallum H, Wood J et al. Transmission or Within-Host Dynamics Driving Pulses of Zoonotic Viruses in Reservoir-Host Populations. PLoS Negl Trop. Dis. 2016; 10 (8): e0004796 10.1371/journal.pntd.0004796 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Epstein JH, Prakash V, Smith CS, Daszak P, McLaughlin AB, Meehan G et al. Henipavirus infection in fruit bats (Pteropus giganteus), India. Emerg Infect Dis. 2008; 14: 1309–1311. 10.3201/eid1408.071492 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Gilbert A, Fooks AR, Hayman DTS, Horton DL, Müller T, Plowright R et al. Deciphering serology to understand the ecology of infectious diseases in wildlife. Ecohealth. 2013; 10: 298–313. 10.1007/s10393-013-0856-0 [DOI] [PubMed] [Google Scholar]
  • 28.Daniels P, Ksiazek T, Eaton BT. Laboratory diagnosis of Nipah and Hendra virus infections. Microbes Infect. 2001; 3: 289–295. 10.1016/s1286-4579(01)01382-x [DOI] [PubMed] [Google Scholar]
  • 29.Bossart KN, McEachern JA, Hickey AC, Choudhry V, Dimitrov DS, Eaton BT et al. Neutralization assays for differential henipavirus serology using Bio-Plex Protein array systems. J Virol Methods. 2007; 142: 29–40. 10.1016/j.jviromet.2007.01.003 [DOI] [PubMed] [Google Scholar]
  • 30.Epstein JH, Baker ML, Zambrana-Torrelio C, Middleton D, Barr JA, Dubovi E, et al. Duration of maternal antibodies against canine distemper virus and Hendra virus in Pteropid bats. PLoS One.2013; 8(6): e67584 10.1371/journal.pone.0067584 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Burroughs AL, Durr PA, Boyd V, Graham K, White JR, Todd S et al. Hendra virus infection dynamics in the grey-headed flying fox (Pteropus poliocephalus) at the southern-most extent of Its range: further evidence this species does not readily transmit the virus to horses. PLoS ONE. 2016; 11 (6): e0155252 10.1371/journal.pone.0155252 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.McNabb L, Barr J, Crameri G, Jusva S, Colling A, Riddell S et al. Henipavirus microsphere immune-assays for detection of antibodies against Hendra virus. J Virol Methods. 2014; 200: 22–28. 10.1016/j.jviromet.2014.01.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Prada D, Boyd V, Baker M, Jackson B, O’Dea M. Insights into Australian Bat Lyssavirus in Insectivorous Bats of Western Australia. Trop Med Infect Dis. 2019; 4: 46 10.3390/tropicalmed4010046 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Hayman DTS, Wang LF, Barr J, Baker KS, Suu-Ire R, Broder CC et al. Antibodies to henipavirus or henipa-like viruses in domestic pigs in ghana, West Africa. PLoS One. 2011; 6 10.1371/journal.pone.0025256 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Peel AJ, Bake KS, Crameri G, Barr JA, Hayman DTS, Wright E et al. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One. 2012; 7 (1): e30346 10.1371/journal.pone.0030346 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Peel AJ, McKinley TJ, Baker KS, Barr JA, Crameri G, Hayman DTS et al. Use of cross-reactive serological assays for detecting novel pathogens in wildlife: Assessing an appropriate cutoff for henipavirus assays in African bats. J Virol Methods. 2013; 193: 295–303. 10.1016/j.jviromet.2013.06.030 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Sendow I, Ratnawati A, Taylor T, Adjid RM, Saepulloh M, Barr J et al. Nipah virus in the fruit bat Pteropus vampyrus in Sumatera, Indonesia. PLoS One. 2013; 8 (7): e69544 10.1371/journal.pone.0069544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Edson D, Field H, McMichael L, Vidgen M, Goldspink L, Broos A et al. Routes of Hendra virus excretion in naturally infected flying-foxes: implications for viral transmission and spillover risk. PLoS One. 2015; 10 (10): e0140670 10.1371/journal.pone.0140670 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Peel AJ, Wells K, Giles J, Boyd V, Burroughs A, Edson D et al. Synchronous shedding of multiple paramyxoviruses coincides with peak periods of Hendra virus spillover. Emerg Micr Infect. 2019; 8: 1314–1323, 10.1080/22221751.2019.1661217 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hall L, Richards G. Flying foxes: fruit and blossom bats of Australia. 2000. Dawson TJ, ed. Sydney: University of New South Wales Press Ltd. [Google Scholar]
  • 41.Williamson MM, Hooper PT, Selleck PW, Westbury HA, Slocombe RF. Experimental Hendra virus infection in pregnant guinea-pigs and fruit bats (Pteropus poliocephalus). J Comp Pathol. 1999; 122201–7. 10.1053/jcpa.1999.0364 [DOI] [PubMed] [Google Scholar]
  • 42.Halpin K, Young PL, Field HE, McKenzie JS. Isolation of Hendra virus from pteropid bats: a natural reservoir of Hendra virus. J Gen Virol. 2008; 1: 1927–1932. [DOI] [PubMed] [Google Scholar]
  • 43.Horby PW, Laurie KL, Cowling BJ, Engelhardt OG, Sturm‐Ramirez K, Sanchez JL et al. CONSISE statement on the reporting of Seroepidemiologic Studies for influenza (ROSES‐I statement): an extension of the STROBE statement. Influenza Other Respir Viruses. 2017; 11: 2–14. 10.1111/irv.12411 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Jonsson NN, Johnston SD, Field H, de Jong C, Smith C. Field anaesthesia of three Australian species of flying fox. Vet Rec. 2004; 154: 664 10.1136/vr.154.21.664 [DOI] [PubMed] [Google Scholar]
  • 45.Schulz JE, Seifert SN, Thompson JT, Avanzato V, Sterling SL, Yan L et al. Serological Evidence for Henipa-like and Filo-like Viruses in Trinidad Bats. J Infect Dis. 2020. jiz648 10.1093/infdis/jiz648 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Laing E, Yan L, Sterling S, Broder C. A Luminex-based multiplex assay for the simultaneous detection of glycoprotein specific antibodies to ebolaviruses, marburgviruses, and henipaviruses. 2016; Int J Infect Dis. 53, Supplement, 108–109. 10.1016/j.ijid.2016.11.272 [DOI] [Google Scholar]
  • 47.Petraityte R, Tamosiunas PL, Juozapaitis M, Zvirbliene A, Sasnauskas K, Shiell B, et al. Generation of Tioman virus nucleocapsid-like particles in yeast Saccharomyces cerevisiae. Virus Res. 2009: 145:92–96. 10.1016/j.virusres.2009.06.013 [DOI] [PubMed] [Google Scholar]
  • 48.Rahmadane I, Certoma AF, Peck GR, Fitria Y, Payne J, Colling A, et al. Development and validation of an immunoperoxidase antigen detection test for improved diagnosis of rabies in Indonesia. PLoS Negl Trop Dis. 2017; 11(11): e0006079 10.1371/journal.pntd.0006079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Cameron A, Njeumi F, Chibeu D. and Martin T. Risk-based disease surveillance. Food and Agriculture Organization of the United Nations; 2015. [Google Scholar]
  • 50.Eby P and Law B. Ranking the feeding habitat of grey-headed flying foxes for conservation management. http://www.environment.nsw.gov.au/resources/threatenedspecies/GHFFmainreport.pdf. 2008 Last accessed on November 5, 2019. 10.1371/journal.pone.0067584 . [DOI] [PMC free article] [PubMed]
  • 51.Giles JR, Plowright RK, Eby P, Peel AJ, McCallum H. Models of Eucalypt phenology predict bat population flux. Ecol Evol. 2016; 6: 7230–7245. 10.1002/ece3.2382 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Plowright RK, Eby P, Hudson PJ, Smith IL, Westcott D, Bryden WL, et al. Ecological dynamics of emerging bat virus spillover. Proc R Soc Lond Biol. 2015; 282: 2014–2124. 10.1098/rspb.2014.2124 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wang HH, Kung NY, Grant WE, Scanlan JC, Field HE. Recrudescent infection supports Hendra virus persistence in Australian flying-fox populations. PLoS One. 2013; 8: 10.1371/journal.pone.0080430 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Peel AJ, Baker KS, Hayman DTS, Broder CC, Cuningham AA, Fooks AR et al. Support for viral persistence from age-specific serology and models of immunity. Nat. Sci. Rep. 2018; 10.1038/s41598-018-22236-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Field HE. Evidence of Australian bat lyssavirus in diverse Australian bat taxa. Zoonoses Public Health. 2018; 65: 742–748 10.1111/zph.12480 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Turmelle AS, Jackson FR, Green D, McCracken GF, Rupprecht CE. Host immunity to repeated rabies virus infection in big brown bats. J Gen Virol. 2010; 91: 2360–2366. 10.1099/vir.0.020073-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Badrane H and Tordo N. Host Switching in Lyssavirus History from the Chiroptera to the Carnivora Orders. J Virol. 2001; 17: 8096–8104. 10.1128/JVI.75.17.8096-8104.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Tidemann CR and Nelson JE. Long-distance movements of the grey-headed flying fox (Pteropus poliocephalus). J Zool. 2004; 263: 141–146. 10.1017/S0952836904004960 [DOI] [Google Scholar]
  • 59.Parsons JG, Van Der Wal J, Robson SKA, Shilton LA. The implications of sympatry in the spectacled and grey headed flying-fox, Pteropus conspicillatus and P. poliocephalus (Chiroptera: Pteropodidae). Acta Chirop. 2010; 12: 301–309. 10.3161/150811010X537882 [DOI] [Google Scholar]
  • 60.Tidemann CR. Biology and management of the Grey-headed Flying-fox, P. poliocephalus. Acta Chirop. 1999; 1: 151–64 [Google Scholar]
  • 61.van der Ree R, McDonnell MJ, Temby ID, Nelson J. and Whittingham E. The establishment and dynamics of a recently established urban camp of (Pteropus poliocephalus) outside their geographic range. J. Zool. 2006; 268: 177–85. 10.1111/j.1469-7998.2005.00005.x [DOI] [Google Scholar]
  • 62.Roberts BJ, Catterall CP, Eby P, Kanowski J. Latitudinal range shifts in Australian flying-foxes: a re-evaluation. Austral Ecol. 2012; 37: 12–22. 10.1111/j.1442-9993.2011.02243.x [DOI] [Google Scholar]
  • 63.Parris KM and Hazell DL. Biotic effects of climate change in urban environments: the case of the Grey-headedFlying-fox (Pteropus poliocephalus) in Melbourne. Biol.Conserv. 2005; 124: 267–76. 10.1016/j.biocon.2005.01.035 [DOI] [Google Scholar]

Decision Letter 0

Wanda Markotter

6 Dec 2019

PONE-D-19-30981

Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the grey-headed flying fox <(Pteropus poliocephalus)>.

PLOS ONE

Dear Dr Boardman,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. by two reviewers. 

In addition to these comments please make all meta data available  either as part of the manuscript or supporting information or deposit this into a public repository and provide the link to this information. 

We would appreciate receiving your revised manuscript by Jan 20 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Wanda Markotter

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

http://www.journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and http://www.journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have reported significance probabilities of 0 in places. Since p=0 is not strictly possible, please correct this to a more appropriate limit, eg 'p<0.0001'.

3. We note that [Figure(s) 1] in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1.    You may seek permission from the original copyright holder of Figure(s) [1] to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2.    If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

4. In your Methods section, please provide additional location information, including geographic coordinates for the data set if available.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Review of ‘Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus, and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the Grey-headed flying fox (Pteropus poliocephalus)

The authors present data on the seroprevalence of bat borne paramyxoviruses through longitudinal sampling using a microsphere multiplex serological assay using surface proteins as targets. They analyze the serological data using finite mixture models on log-transformed MFI values to determine distributions and assign categories of seronegative, seropositive or intermediates and then use hurdle modelling to correlate seropositivity and titre (MFI value). As more serological datasets are generated from species with no true positive or negative controls, it’s important that there are advanced analysis of these data. Longitudinal sampling is needed to understand temporal patterns of virus periodicity and, by proxy, relative risk. Setting up and conducting longitudinal surveillance projects requires significant foresight and a significant allocation of time, expenses and personnel. The manuscript is well written and presents compelling data on the seroprevalence of multiple bat paramyxoviruses. There are revisions required before this manuscript can be accepted.

Major revisions

• I believe that the introduction and discussion can be streamlined. The introduction is 8 paragraphs and the discussion is 9 paragraphs. There is much salient data in these sections, but they should be cut down for the benefit of the reader.

• The methods section for the serology, which plays an integral role in the study results, is not detailed enough. The authors should provide a significantly more detailed section including; the proteins (target and how they are produced, if samples were run in duplicate/triplicate, what machine they were run on. I understand that the authors are referencing a previous study, but I imagine details in the bat handling and serum collection could be similarly truncated with a reference to similar approaches. Additionally, reference 31 in this section is for nucleic acid detection and not antibody detection and needs to be removed.

• Have the authors looked at the significance of using weight only as opposed to using body condition index when studying seroprevalence. A meta-analysis done by McGuire et al 2018 (https://doi.org/10.1093/jmammal/gyy103) found that there was no support that, “bats with longer forearms weigh more than bats with shorter forearms”. They note that the relationship between body mass and forearm length was very weak. Is this the case in Pteropus poliocephalus and is BCI an appropriate metric to study?

• The only reference to raw MFI values was in the recapture data. There was no supplementary table with the MFI values. The authors should include this data and it would help if they added a scatterplot or box plot with these values for each virus glycoprotein with the lower and upper thresholds noted. Or they can add a secondary x-axis on figure 2 to know what the MFI values are. This is important because these multiplex serological assays are being implemented on pteropodid bats across South and Southeast Asia and it’s important for comparative studies to know what raw MFI values are for seropositives and seronegatives.

• The authors should be cautious when they use the word antibody titres in the text and in the methods and results section headers. They state that antibody titre is expressed as MFI, but titre has a specific meaning. Have the authors run an endpoint dilution to then correlate that endpoint with MFI detection values? If they have not, then they should not use the word titre.

Minor revisions

Abstract

• Line 37: What does ‘camp antibody’ titres mean?

Introduction

• Lines 52&53: Check duplicate references

• Line 72: Is there a reference for the range expansion of the species?

• Line 76: What does ‘incidentally detected’ mean?

• Line 82: Please use another word for elusive

• Line 88-89: The authors should mention the conformational state of the proteins in these tests as native state antigens will represent what the immune systems sees compared to linear peptides.

• Line 97: The authors use both recrudescence and reactivation in this manuscript. Please use one or the other for consistency.

Materials and Methods

• Line 144: What is the company that makes the mist nets?

• How is a subadult defined?

• Is estimated age a subjective categorical variable? Please explain.

• How was the sera treated before the test? Was it heat inactivated? Was is gamma inactivated?

• Line 169: Was the concentration of antibodies measured? It is better to state that antibodies were detected against the different viruses in the panel

• Line 172: Please remove reference 31 as it does not refer to antibodies

• Line 183 section: Were any priors used for Hendra and Cedar virus when running the models? There were priors used and noted for Australian bat lyssavirus, but none are mentioned for these two henipaviruses, even though there are previous studies studying seroprevalence. Noted in line 339-343

• Line 196: Can you please explain how threshold values were ‘visually determined’?

Results

• In the demographic section, some description of the collections would be helpful (adults compared to sub adults and males compared to females). I understand this is noted in the table, but some more detail in the text would be helpful.

• The rest of the results reads well.

Discussion

• Are there specific periods of birthing in this species? There is a lot of natural history information, but I did not note this important fact.

• Line 376: The authors note that their findings support the SIRS and SILI models. Can they expand on this statement in this paragraph.

• Line 401: Why wasn’t there an association between co-serostatus?

• Line 413: The authors can reference Peel et al’s work on Africa henipavirus immunity duration (DOI: 10.1038/s41598-018-22236-6) and Schuh et al 2019 (Comparative analysis of serologic cross-reactivity using convalescent sera from filovirus-experimentally infected fruit bats) and this would support their discussion on cross-reactivity and decay in filoviruses.

• Line 438-439: There are references to specific MFI values, but there are for both henipaviruses and lyssaviruses. This sentence needs to be more detailed as to which MFI values correspond to what specific viruses.

• Line 446: The author’s reference the specific thresholds for MFI values and having an additional figure with the non-transformed MFI values would help.

• Line 454-456: was there a reason why it wasn’t possible to collect urine to establish virus prevalence?

• Line 466-467: The authors state that there is no significant co-occurance of the studied viruses, but they did not test for viruses. They only studied seroprevalence.

Table 2:

• It would be beneficial to have the range of MFI values and the median values for seropositives in this table.

Figures

• Figure 1 looks to be from google maps. That satellite image from a copyrighted source may not be publishable under the PLOS Open Access CC-BY License

Reviewer #2: This manuscript describes a three year serological study of grey-headed flying-foxes at a single roost site in South Australia. Tests on sera collected were conducted for evidence of exposure to four viral pathogens and analyses performed to identify risk factors for exposure and patterns of infection.

The text is generally very well written and the key points are clearly communicated, however I have some concerns with the interpretation of the results and their significance.

Major comments:

1 – There are various terms used to describe the study site and the group of animals sampled - “colony” “flying fox camp” “Adelaide grey-headed flying fox population”. Clarification of the terms used is necessary to interpret the results and understand their significance.

2 - From an epidemiological perspective – what is the study population? i.e. which group of flying foxes constituted the sampling frame from which the sample were drawn?

The text includes “immigration of approximately 10,000 extra grey-headed flying foxes into the Adelaide camp”. Where did these bats come from? The reader needs to have a clear understanding of the group of flying foxes that could have been selected for sampling in this study, e.g. to understand the potential bias in only sampling from one location.

3 – what is the target population? i.e. to which group of flying-foxes are the results of this study to be applied? This is relevant to clarify when considering which previous studies are appropriate to include for comparison of results in the Discussion. And to consider the application and relevance of these results to other flying-fox populations/roosts/species etc.

The term “Adelaide colony” is used frequently in the text but it seems evident that the group of bats present at the roost site in Adelaide does not constitute a “colony” in the biological sense of the word. “Roost” or “camp” site would seem more appropriate given the evidence of long-distance travel and high level of genetic mixing of this species. I understand the two questions above may be difficult, or not possible, to answer with high confidence. But if this is the case, then this should be explicitly explained and discussed. Perhaps two or more hypotheses could be presented for potential study and target populations, and then the results and conclusions considered in light of different potential population definitions.

Regarding the demonstration of freedom of infection from ABLV:

4 - The stated assumption of perfect accuracy of the Luminex assay seems unreasonable without strong supporting evidence. Methods are readily available for analysis of results with assumptions of imperfect sensitivity and specificity of a diagnostic test and this would seem more reasonable.

5 - There is a statement in the Discussion that it is possible the “antigen used in the Luminex assay no longer contains a relevant epitope”. Further work to clarify this would seem necessary to interpret the results. How does the antigen in the assay compare to those found on the corresponding virus detected in Adelaide in 2012?

6 – The freedom from infection calculations require clarification or greater explanation in the context of clarification of the definition of the “Adelaide colony” i.e. the target and study populations. Which group of bats is being considered free from infection? Are the “10,000 extra bats” included in this?

7 – Given the statement “Freedom from Australian bat lyssavirus was deemed achieved if the estimated probability of freedom was ≥ 95%.” What does ≥ 95% mean in this context? How can this be useful?

8 – given the comments 4-7 above, I’m not convinced that demonstration of freedom from infection is very meaningful or useful in this context. Please provide explanation of the purpose in using the “freedom of infection” approach.

Minor comments:

9 – the discussion on infection dynamics and previous studies is useful but could be greatly improved through clarification of the target and study populations in this study. Currently it seems rather speculative.

10 – Re the statement “Uniquely, four recaptures of individuals over the sampling period provided some information on the infection dynamics of these viruses”. In what context is this unique?

Also, data from the recapture of such a small number of individuals seems more like interesting data to perhaps guide future studies rather than true information on infection dynamics. Particularly in light of the limitation of the tests used and uncertainty of the viruses to which the bats have been exposed.

11 – Re the statement “there is no evidence of how long titres might last in adults”. I think some of the previous studies referred to in the Introduction and Discussion have some evidence on this. At least with regards to potential models of infection dynamics and duration of immunity.

12 – it would be helpful to provide confidence intervals for the seroprevalences measured for ABLV in previous studies to aid interpretation of results from this study.

13 – re the statement “overlap of flying fox species coupled with their range expansions, transmission and infection may occur anywhere along the distribution range”. I do not see that range expansions are required for transmission and infection to occur throughout the range of Australian flying-fox species.

14 – re the statement “its possible that the high seropositivity to Tioman virus could reflect exposure due to either or both viruses at different times.” Given the evidence of Menangle virus and not Tioman virus presence in Australia, why test for Tioman antibodies and not Menangle antibodies? Or at least conduct a study to estimate the degree of cross reactivity of antibodies in this species.

15 – the statements “all four species of mainland Australian pteropids” and “one of five species of flying foxes found in Australia,” appear potentially contradictory, please clarify.

16 – lines 325-326 I think “did not become infected” should be “did not show evidence of exposure”

17 – regarding the statements on reasons for not sampling during October to December and April to May. How was the potential detrimental effect of sampling during these times determined? How is this reconciled with the stated conclusion to “include more sampling periods over an annual cycle”?

18 – please check for minor typographical errors e.g. lines 84-85, line 405 “its” should be “it is”

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

Decision Letter 1

Wanda Markotter

14 Apr 2020

Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the grey-headed flying fox <(Pteropus poliocephalus)>.

PONE-D-19-30981R1

Dear Dr. Boardman,

We are pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it complies with all outstanding technical requirements.

Within one week, you will receive an e-mail containing information on the amendments required prior to publication. When all required modifications have been addressed, you will receive a formal acceptance letter and your manuscript will proceed to our production department and be scheduled for publication.

Shortly after the formal acceptance letter is sent, an invoice for payment will follow. To ensure an efficient production and billing process, please log into Editorial Manager at https://www.editorialmanager.com/pone/, click the "Update My Information" link at the top of the page, and update your user information. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, you must inform our press team as soon as possible and no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

With kind regards,

Wanda Markotter

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all the comments in this revised version. We thank them for providing a comprehensive set of edits that have improved the manuscript.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Acceptance letter

Wanda Markotter

22 Apr 2020

PONE-D-19-30981R1

Seroprevalence of three paramyxoviruses; Hendra virus, Tioman virus, Cedar virus and a rhabdovirus, Australian bat lyssavirus, in a range expanding fruit bat, the grey-headed flying fox (Pteropus poliocephalus).

Dear Dr. Boardman:

I am pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please notify them about your upcoming paper at this point, to enable them to help maximize its impact. If they will be preparing press materials for this manuscript, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

For any other questions or concerns, please email plosone@plos.org.

Thank you for submitting your work to PLOS ONE.

With kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Prof Wanda Markotter

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Table. Catching information, demographic data, morphometrics and MFI values for Hendra virus, Cedar virus, Tioman virus and Australian bat lyssa virus for each sampled bat.

    (XLSX)

    Attachment

    Submitted filename: BOARDMAN Rebuttal Letter_V03.docx

    Data Availability Statement

    All relevant data are within the manuscript and its Supporting Information files.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES